Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-03-13 | Myla P. Lai-Goldman, M.D., 66, Independent, Chair and Former CEO and President, GeneCentric Therapeutics, Inc. (2011-present), Director Since 2014, Committees: Finance, Innovation & Technology (Chair). 2023 Non-Employee Director Compensation: Total $359,348. |
| 2025-03-21 | Myla P. Lai-Goldman, M.D., 67, Independent, Chair and Former CEO GeneCentric Therapeutics, Inc. (2011-present), Director Since 2014, Committees: Finance, Innovation & Technology (Chair). 2024 Non-Employee Director Compensation: Total $359,252. |
Data sourced from SEC filings. Last updated: 2025-07-16